Correlation Between Kiromic Biopharma and Sigilon Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kiromic Biopharma and Sigilon Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiromic Biopharma and Sigilon Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiromic Biopharma and Sigilon Therapeutics, you can compare the effects of market volatilities on Kiromic Biopharma and Sigilon Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiromic Biopharma with a short position of Sigilon Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiromic Biopharma and Sigilon Therapeutics.
Diversification Opportunities for Kiromic Biopharma and Sigilon Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Kiromic and Sigilon is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Kiromic Biopharma and Sigilon Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sigilon Therapeutics and Kiromic Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiromic Biopharma are associated (or correlated) with Sigilon Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sigilon Therapeutics has no effect on the direction of Kiromic Biopharma i.e., Kiromic Biopharma and Sigilon Therapeutics go up and down completely randomly.
Pair Corralation between Kiromic Biopharma and Sigilon Therapeutics
If you would invest (100.00) in Sigilon Therapeutics on November 27, 2024 and sell it today you would earn a total of 100.00 from holding Sigilon Therapeutics or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kiromic Biopharma vs. Sigilon Therapeutics
Performance |
| Timeline |
| Kiromic Biopharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| Sigilon Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Kiromic Biopharma and Sigilon Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiromic Biopharma and Sigilon Therapeutics
The main advantage of trading using opposite Kiromic Biopharma and Sigilon Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiromic Biopharma position performs unexpectedly, Sigilon Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sigilon Therapeutics will offset losses from the drop in Sigilon Therapeutics' long position.| Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
| Sigilon Therapeutics vs. Reviva Pharmaceuticals Holdings | Sigilon Therapeutics vs. ZyVersa Therapeutics | Sigilon Therapeutics vs. Unicycive Therapeutics | Sigilon Therapeutics vs. Apollomics Class A |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |